TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
126
|
107
|
104 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
38
|
18
|
33 |
| EBITDA |
37
|
17
|
31 |
| Total assets |
172
|
159
|
162 |
| Current assets |
117
|
113
|
136 |
| Current liabilities |
15
|
18
|
6 |
| Equity capital |
145
|
130
|
147 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
84.3%
|
81.8%
|
90.7% |
| Turnover per employee |
126
|
107
|
104 |
| Profit as a percentage of turnover |
30.2%
|
16.8%
|
31.7% |
| Return on assets (ROA) |
22.1%
|
11.3%
|
20.4% |
| Current ratio |
780.0%
|
627.8%
|
2266.7% |
| Return on equity (ROE) |
26.2%
|
13.8%
|
22.4% |
| Change turnover |
23
|
3
|
1 |
| Change turnover % |
22%
|
2%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.